-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明，无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Pfizer CEO Says People Needing COVID-19 Vaccines Every Year Is The 'Most Likely Scenario'
Pfizer CEO Says People Needing COVID-19 Vaccines Every Year Is The 'Most Likely Scenario'
Pfizer Inc (NYSE:PFE) CEO Albert Bourla said that there is a likelihood that annual booster shots of the coronavirus vaccine will be needed.
What Happened: Bourla said in an interview with ABC’s “This Week” program that the COVID-19 vaccine could morph into an annual shot.
See Also: How To Buy Pfizer (PFE) Shares
“The most likely scenario for me is that, because the virus is spread all over the world, that it will continue seeing new variants that are coming out,” he said.
“Also we will have vaccines that they will last at least a year, and I think the most likely scenario is annual vaccination, but we don’t know really, we need to wait and see the data,” Bourla said.
The Pfizer CEO anticipates that "we will be able to come back to normal life” within a year.
Why It Matters: The Pfizer vaccine booster shot was approved by FDA for high-risk individuals, and for those aged 65 years and above last week.
See Also: EMA To Decide On Pfizer/BioNTech COVID-19 Booster Next Month: Reuters
Bourla’s comment that normal life could return within a year came with a caveat on emerging variants of COVID-19 and the need for continuing vaccination.
“I don’t think that this means that the variants will not continue coming, and I don’t think that this means that we should be able to live our lives without having vaccinations,” he said.
Bourla’s timeline for the end of the pandemic is similar to that proposed by Moderna Inc (NASDAQ:MRNA) CEO Stéphane Bancel.
Bancel said he expected things to return to normal a year from now when asked by the Swiss newspaper Neue Zuercher Zeitung on an estimated return to normal life, as per a Reuters report.
Pfizer CEO said in the interview, the company was going to submit data on a children’s COVID-19 vaccine in a matter of “days,” not “weeks.”
Pfizer’s vaccine is made in partnership with the German firm BioNTech SE (NASDAQ:BNTX).
Price Action: On Friday, Pfizer shares closed nearly 0.6% lower at $43.94 in regular trading. On the same day, BioNTech shares closed nearly 5.5% lower in the regular session at $333.48 and rose almost 0.6% higher to $333.50 in the after-hours trading.
Read Next: Amazon Dishes Out Cars, $100K In Rewards To Workers As It Seeks To Encourage Staff Vaccination
Pfizer Inc (NYSE:PFE) CEO Albert Bourla said that there is a likelihood that annual booster shots of the coronavirus vaccine will be needed.
辉瑞纽约证券交易所代码：PFE)首席执行官阿尔伯特·鲍拉说有可能需要每年一次的冠状病毒疫苗强化注射。
What Happened: Bourla said in an interview with ABC’s “This Week” program that the COVID-19 vaccine could morph into an annual shot.
发生的事情：布拉在一次采访中说采访随着美国广播公司的“本周”节目，新冠肺炎疫苗可能会变成一年一度的疫苗。
See Also: How To Buy Pfizer (PFE) Shares
“The most likely scenario for me is that, because the virus is spread all over the world, that it will continue seeing new variants that are coming out,” he said.
他说：“对我来说，最有可能的情况是，由于病毒在世界各地传播，它将继续看到新的变种出现。”
“Also we will have vaccines that they will last at least a year, and I think the most likely scenario is annual vaccination, but we don’t know really, we need to wait and see the data,” Bourla said.
Bourla说：“我们的疫苗将至少持续一年，我认为最有可能的情况是每年接种疫苗，但我们真的不知道，我们需要等待数据。”
The Pfizer CEO anticipates that "we will be able to come back to normal life” within a year.
这位辉瑞首席执行官预计，“我们将能够在一年内恢复正常生活”。
Why It Matters: The Pfizer vaccine booster shot was approved by FDA for high-risk individuals, and for those aged 65 years and above last week.
重要的原因：辉瑞公司的疫苗增强剂是FDA批准对于高危个人，以及上周65岁及以上的人。
Bourla’s comment that normal life could return within a year came with a caveat on emerging variants of COVID-19 and the need for continuing vaccination.
布拉发表评论称，正常生活可能会在一年内恢复，但同时也对新兴的新冠肺炎变种提出了警告，并表示需要继续接种疫苗。
“I don’t think that this means that the variants will not continue coming, and I don’t think that this means that we should be able to live our lives without having vaccinations,” he said.
他说：“我不认为这意味着变种病毒不会继续出现，我也不认为这意味着我们不接种疫苗就可以生活下去。”
Bourla’s timeline for the end of the pandemic is similar to that proposed by Moderna Inc (NASDAQ:MRNA) CEO Stéphane Bancel.
Bourla提出的结束大流行的时间表与Moderna(纳斯达克：信使核糖核酸)首席执行官斯特凡·班塞尔。
Bancel said he expected things to return to normal a year from now when asked by the Swiss newspaper Neue Zuercher Zeitung on an estimated return to normal life, as per a Reuters report.
据路透社报道，当瑞士报纸Neue Zuercher Zeitung问及预计恢复正常生活时，班塞尔表示，他预计一年后情况将恢复正常报告.
Pfizer CEO said in the interview, the company was going to submit data on a children’s COVID-19 vaccine in a matter of “days,” not “weeks.”
辉瑞首席执行官在采访中表示，该公司将提交关于儿童新冠肺炎疫苗只需“几天”，而不是“几周”。
Pfizer’s vaccine is made in partnership with the German firm BioNTech SE (NASDAQ:BNTX).
Price Action: On Friday, Pfizer shares closed nearly 0.6% lower at $43.94 in regular trading. On the same day, BioNTech shares closed nearly 5.5% lower in the regular session at $333.48 and rose almost 0.6% higher to $333.50 in the after-hours trading.
辉瑞的疫苗是与这家德国公司合作生产的BioNTech SE(纳斯达克：BNTX). 价格行动：周五，辉瑞股价在常规交易时段收低近0.6%，报43.94美元。同一天，生物科技的股价在常规交易时段收盘下跌近5.5%，至333.48美元，在盘后交易中上涨近0.6%，至333.50美元。
Read Next: Amazon Dishes Out Cars, $100K In Rewards To Workers As It Seeks To Encourage Staff Vaccination
接下来请阅读：亚马逊推出汽车，10万美元奖励工人，以鼓励员工接种疫苗
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能，分享给你的好友吧